TCL Archive As For-Profits Provide Phase I Studies, NCI Seeks to Look Deeper and Learn More April 6, 2012
TCL Archive Controversial Toxicology Protocol Is “Getting The Information We Need;” Additionally Revision Made March 2, 1984
TCL Archive Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients December 28, 2012